8IJA

Cryo-EM structure of human HCAR2-Gi complex with niacin

8IJA の概要

• エントリーDOI: 10.2210/pdb8ija/pdb
• EMDBエントリー: 35483
• 分子名称: Hydroxycarboxylic acid receptor 2, Guanine nucleotide-binding protein G(i) subunit alpha-1, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, ... (6 entities in total)
• 機能のキーワード: complex, membrane protein
• 由来する生物種: Homo sapiens (human); 詳細
• タンパク質・核酸の鎖数: 5
• 化学式量合計: 144240.84

構造登録者

Pan, X.,Fang, Y. (登録日: 2023-02-26, 公開日: 2024-01-03, 最終更新日: 2024-10-16)

主引用文献

Pan, X.,Ye, F.,Ning, P.,Zhang, Z.,Li, X.,Zhang, B.,Wang, Q.,Chen, G.,Gao, W.,Qiu, C.,Wu, Z.,Li, J.,Zhu, L.,Xia, J.,Gong, K.,Du, Y.
Structural insights into ligand recognition and selectivity of the human hydroxycarboxylic acid receptor HCAR2.
Cell Discov, 9:118-118, 2023

PubMed Abstract: Hydroxycarboxylic acid receptor 2 (HCAR2) belongs to the family of class A G protein-coupled receptors with key roles in regulating lipolysis and free fatty acid formation in humans. It is deeply involved in many pathophysiological processes and serves as an attractive target for the treatment of cardiovascular, neoplastic, autoimmune, neurodegenerative, inflammatory, and metabolic diseases. Here, we report four cryo-EM structures of human HCAR2-Gi1 complexes with or without agonists, including the drugs niacin (2.69 Å) and acipimox (3.23 Å), the highly subtype-specific agonist MK-6892 (3.25 Å), and apo form (3.28 Å). Combined with molecular dynamics simulation and functional analysis, we have revealed the recognition mechanism of HCAR2 for different agonists and summarized the general pharmacophore features of HCAR2 agonists, which are based on three key residues R111, S179, and Y284. Notably, the MK-6892-HCAR2 structure shows an extended binding pocket relative to other agonist-bound HCAR2 complexes. In addition, the key residues that determine the ligand selectivity between the HCAR2 and HCAR3 are also illuminated. Our findings provide structural insights into the ligand recognition, selectivity, activation, and G protein coupling mechanism of HCAR2, which shed light on the design of new HCAR2-targeting drugs for greater efficacy, higher selectivity, and fewer or no side effects.

PubMed: 38012147
DOI: 10.1038/s41421-023-00610-7

実験手法

ELECTRON MICROSCOPY (2.69 Å)